Canadian pharmaceutical industry lobby groups, in an effort to head off a planned crackdown on prescription drug prices, offered to give up $8.6 billion in revenue over 10 years, freeze prices or reduce the cost of treating rare diseases, Reuters reports.
from CBC | Health News http://bit.ly/2HW5oUf
Aucun commentaire:
Enregistrer un commentaire